AUERBACH ALAN H 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Feb 14, 2023
Insider Transaction Report
Form 4
AUERBACH ALAN H
DirectorPresident and CEO10% Owner
Transactions
- Award
Common Stock
2023-02-10+186,403→ 7,039,041 total - Award
Stock Option (Right to Buy)
2023-02-10+258,924→ 258,924 totalExercise: $4.39Exp: 2033-02-09→ Common Stock (258,924 underlying)
Footnotes (2)
- [F1]Subject to Grantee's continued status as an Employee of the Company, the Restricted Stock Units ("RSUs") shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2023, January 1, 2024, July 1, 2024 and January 1, 2025, subject to acceleration in certain events.
- [F2]Subject to Optionee's continued status as an Employee of the Company, Options shall vest and become exercisable with respect to one-fourth (1/4th) of the Shares (as defined in the Plan) subject thereto on each of July 1, 2023, January 1, 2024, July 1, 2024 and January 1, 2025, subject to acceleration in certain events.